NEW YORK (PRWEB)
June 22, 2023
The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of New York for 2023. This year’s awardees represent some of the most highly influential and forward-thinking companies in various sectors within the Empire State. These sectors span from life sciences and medical devices, to home services and more. With their profound operational and scientific knowledge, these healthcare technology leaders have played a pivotal role in driving remarkable growth and advancement within their respective organizations. Simultaneously, they have brought forth invaluable products and services that have greatly benefited customers not only in New York, but around the globe.
One of the distinguished individuals recognized this year is Avi Benshoshan, who holds the position of SVP of Global Market Access at Merck, the biopharmaceutical giant that has been around for more than 130 years; and was recently ranked 71st on the 2022 Fortune 500. Another esteemed honoree is Kalpana Vanam, who brings nearly four decades’ worth of experience to her position as SVP of Generics, Specialty, and Biosimilar at Lupin Pharmaceuticals, which is amongst the largest generic pharmaceutical companies in the world. Furthermore, Puja Sapra, who serves as Senior Vice President, Head of R&D Biologics Engineering, and Head of Oncology Targeted Delivery for AstraZeneca, has made significant contributions as a leader and researcher. During her lengthy career, Sapra has authored more than 75 scientific publications and book chapters – while also being recognized as the inventor or co-inventor of more than 25 patents in the field.
Please join us in celebrating The Top 25 Healthcare Technology Leaders of New York for 2023.
Ivan Tornos (Zimmer Biomet), Nelly Nauman (Parexel), Erik Lium (Mount Sinai Health System), Kim Gold (Genentech), Nolan Bennett (Otsuka Pharmaceutical Companies), Ashu Tandon (MMS), Gregory Ryslik (Compass Pathways), Mark Hillebrandt (Henry Schein), Lisa Martin (GSK), Scott Seidelmann (Omnicell), Tanya Luckie (Johnson & Johnson), Indranil Nandi (Jubilant Radiopharma), Irene Chui (MicroPort Orthopedics Inc.), Avi Benshoshan (Merck), Sridhar Shankar (Sun Pharma), Lars Strassenburg (Siemens Healthineers), Puja Sapra (AstraZeneca), Francisco Ramirez-Valle (Bristol Myers Squibb), Thomas Seck (Boehringer-Ingelheim), Greg Raskin (Memorial Sloan Kettering Cancer Center), Neelesh Chudasama (Frontier Medicines), Kalpana Vanam (Lupin Pharmaceuticals), Carolyn Amato (Edwards Lifesciences), Anna Upton (Evotec) and Charlotte Jones-Burton (Chinook Therapeutics, Inc.).
The full article can be read at https://thehealthcaretechnologyreport.com/.
About The Healthcare Technology Report
The Healthcare Technology Report provides market research and insights, business news, investment activity updates and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on healthcare technology and the various companies, executives and investors that make up the sector.
Share article on social media or email: